03 September 2021>: Clinical Research
Genital Human Papillomavirus Prevalence and Genotyping Among Males in Putuo District of Shanghai, China 2015–2019
Xiaoxiao Li ACDEG , Fenfen Xiang C , Zixi Chen D , Tao Zhang B , Zhaowei Zhu BC , Mengzhe Zhang BF , Rong Wu DG* , Xiangdong Kang A*DOI: 10.12659/MSM.932093
Med Sci Monit 2021; 27:e932093
Table 2 Distribution of infection in patients from sexually transmitted disease clinic with 27 genotypes of human papillomavirus from 2015 to 2019.
HPV genotype | Positive cases | Percentage for whole sample (%) | 95% CI for whole sample (%) | 2015 (n=203) | 2016 (n=254) | 2017 (n=241) | 2018 (n=248) | 2019 (n=281) | χ2 | P | gamma value |
---|---|---|---|---|---|---|---|---|---|---|---|
Any HPV | 804 | 65.5 | (62.9–68.2) | 136 (67.0) | 178 (70.1) | 159 (66.0) | 151 (60.9) | 180 (64.1) | 2.542 | 0.111 | −0.068 |
Low-risk | 707 | 57.6 | (54.9–60.4) | 110 (54.2) | 162 (63.8) | 141 (58.5) | 127 (51.2) | 167 (59.4) | 0.093 | 0.760 | −0.013 |
HPV-6 | 393 | 32.0 | (29.4–34.6) | 61 (30.0) | 97 (38.2) | 77 (32.0) | 55 (22.2) | 103 (36.7) | 0.069 | 0.792 | −0.01 |
HPV-11 | 285 | 23.2 | (20.9–25.6) | 41 (20.2) | 57 (22.4) | 54 (22.4) | 69 (27.8) | 64 (22.8) | 1.242 | 0.265 | 0.052 |
HPV-40 | 20 | 1.6 | (0.9–2.3) | 5 (2.5) | 8 (3.1) | 1 (0.4) | 4 (1.6) | 2 (0.7) | 3.989 | 0.046 | −0.318 |
HPV-42 | 17 | 1.4 | (0.7–2.0) | 4 (2.0) | 4 (1.6) | 3 (1.2) | 2 (0.8) | 4 (1.4) | 0.504 | 0.478 | −0.119 |
HPV-43 | 53 | 4.3 | (3.2–5.5) | 14 (6.9) | 12 (4.7) | 7 (2.9) | 9 (3.6) | 11 (3.9) | 2.394 | 0.122 | −0.150 |
HPV-44 | 26 | 2.1 | (1.3–2.9) | 6 (3.0) | 5 (2.0) | 1 (0.4) | 5 (2.0) | 9 (3.2) | 0.158 | 0.691 | 0.062 |
HPV-61 | 34 | 2.8 | (1.9–3.7) | 7 (3.4) | 11 (4.3) | 6 (2.5) | 4 (1.6) | 6 (2.1) | 2.653 | 0.103 | −0.200 |
HPV-81 | 28 | 2.3 | (1.4–3.1) | 6 (3.0) | 5 (2.0) | 4 (1.7) | 6 (2.4) | 7 (2.5) | 0.003 | 0.954 | −0.005 |
High-risk | 344 | 28.0 | (25.5–30.5) | 75 (36.9) | 80 (31.5) | 54 (22.4) | 70 (28.2) | 65 (23.1) | 10.626 | 0.001 | −0.145 |
HPV-16 | 69 | 5.6 | (4.3–6.9) | 13 (6.4) | 19 (7.5) | 12 (5.0) | 11 (4.4) | 14 (5.0) | 1.621 | 0.203 | −0.111 |
HPV-18 | 30 | 2.4 | (1.6–3.3) | 10 (4.9) | 6 (2.4) | 3 (1.2) | 6 (2.4) | 5 (1.8) | 3.234 | 0.072 | −0.229 |
HPV-26 | 4 | 0.3 | (0.0–0.6) | 0 (0.0) | 3 (1.2) | 0 (0.0) | 1 (0.4) | 0 (0.0) | 0.787 | 0.375 | −0.330 |
HPV-31 | 4 | 0.3 | (0.0–0.6) | 1 (0.5) | 0 (0.0) | 0 (0.0) | 2 (0.8) | 1 (0.4) | 0.290 | 0.590 | 0.193 |
HPV-33 | 7 | 0.6 | (0.1–1.0) | 1(0.5) | 3 (1.2) | 2 (0.8) | 1 (0.4) | 0 (0.0) | 1.716 | 0.190 | −0.357 |
HPV-35 | 18 | 1.5 | (0.8–2.1) | 3(1.5) | 4 (1.6) | 3 (1.2) | 3 (1.2) | 5 (1.8) | 0.018 | 0.893 | 0.025 |
HPV-39 | 28 | 2.3 | (1.4–3.1) | 5 (2.5) | 8 (3.1) | 3 (1.2) | 7 (2.8) | 5 (1.8) | 0.362 | 0.547 | −0.083 |
HPV-45 | 12 | 1.0 | (0.4–1.5) | 4 (2.0) | 1 (0.4) | 5 (2.1) | 1 (0.4) | 1 (0.4) | 2.377 | 0.123 | −0.310 |
HPV-51 | 40 | 3.3 | (2.3–4.3) | 14 (6.9) | 8 (3.1) | 3 (1.2) | 10 (4.0) | 5 (1.8) | 5.714 | 0.017 | −0.265 |
HPV-52 | 42 | 3.4 | (2.4–4.4) | 10 (4.9) | 7 (2.8) | 9 (3.7) | 5 (2.0) | 11 (3.9) | 0.329 | 0.566 | −0.059 |
HPV-53 | 33 | 2.7 | (1.8–3.6) | 8 (3.9) | 7 (2.8) | 3 (1.2) | 6 (2.4) | 9 (3.2) | 0.145 | 0.703 | −0.043 |
HPV-55 | 15 | 1.2 | (0.6–1.8) | 4 (2.0) | 2 (0.8) | 3 (1.2) | 4 (1.6) | 2 (0.7) | 0.503 | 0.478 | −0.129 |
HPV-56 | 38 | 3.1 | (2.1–4.1) | 8 (3.9) | 6 (2.4) | 6 (2.5) | 10 (4.0) | 8 (2.8) | 0.006 | 0.940 | −0.008 |
HPV-58 | 33 | 2.7 | (1.8–3.6) | 5 (2.5) | 10 (3.9) | 8 (3.3) | 6 (2.4) | 4 (1.4) | 1.589 | 0.208 | −0.161 |
HPV-59 | 49 | 4.0 | (2.9–5.1) | 10 (4.9) | 15 (5.9) | 9 (3.7) | 9 (3.6) | 6 (2.1) | 4.304 | 0.038 | −0.215 |
HPV-66 | 34 | 2.8 | (1.9–3.7) | 5 (2.5) | 11 (4.3) | 3 (1.2) | 6 (2.4) | 9 (3.2) | 0.020 | 0.886 | 0.017 |
HPV-68 | 2 | 0.2 | (0.0–0.4) | 0 (0.0) | 1 (0.4) | 0 (0.0) | 0 (0.0) | 1 (0.4) | 0.145 | 0.704 | 0.198 |
HPV-82 | 16 | 1.3 | (0.7–1.9) | 2 (1.0) | 3 (1.2) | 2 (0.8) | 5 (2.0) | 4 (1.4) | 0.525 | 0.469 | 0.128 |
HPV-83 | 6 | 0.5 | (0.1–0.9) | 2 (1.0) | 3 (1.2) | 0 (0.0) | 1 (0.4) | 0 (0.0) | 3.848 | 0.050 | −0.562 |
HPV – human papillomavirus. |